Posts in Knowledge Base

The EU Joint Clinical Assessment: What It Means for Your Product

From January 2025, the way new medicines are clinically assessed in Europe changed. The Joint Clinical Assessment (JCA) introduces a single, EU-wide evaluation of clinical[…]

From Approval to Access: How Reimbursement Really Works in Greece

A marketing authorization lets you sell a medicine. Reimbursement is what lets patients actually receive it. In Greece, the two are separate processes — and[…]

Navigating EOF Marketing Authorizations: What Sponsors Need to Know

Bringing a medicine to the Greek market starts with a marketing authorization — but the route you choose, and how well your dossier is prepared,[…]

1 … 7 8 9